CAN
CORT icon

Cetera Advisor Networks’s Corcept Therapeutics CORT Stock Holding History

Cetera Advisor Networks’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$439K Buy
+17,445
New +$412K ﹤0.01% 2016
2021
Q1 		– Sell
-10,157
Closed -$266K – 1487
2020
Q4 		$266K Buy
+10,157
New +$214K 0.01% 1109

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Cetera Advisor Networks's CORT Position: Q1 2024 in Review

Cetera Advisor Networks opened a new position in Corcept Therapeutics (CORT) in Q1 2024: 17,445 shares worth $439K. The stake represents ﹤0.01% of the portfolio and ranks #2016 among its holdings. This is a return to the name: Cetera Advisor Networks previously reported a position in CORT as recently as Q4 2020.

Cetera Advisor Networks first reported a position in CORT in Q4 2020 and has held it in 2 quarters since. 287 funds tracked by Wall St. Rank hold CORT as of Q1 2024.

  • Cetera Advisor Networks held 17,445 shares of Corcept Therapeutics worth $439K as of Q1 2024.
  • Corcept Therapeutics was a new Cetera Advisor Networks position in Q1 2024.
  • Corcept Therapeutics made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2016 holding.
  • Cetera Advisor Networks first reported a position in Corcept Therapeutics in Q4 2020 and has held it in 2 quarters since.
  • 287 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.